Equities researchers at StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS - Get Free Report) in a report issued on Sunday. The brokerage set a "hold" rating on the stock.
Milestone Scientific Stock Down 3.8%
NYSE:MLSS opened at $0.90 on Friday. The stock's 50 day moving average price is $0.95 and its 200 day moving average price is $0.97. The company has a market capitalization of $70.15 million, a PE ratio of -12.78 and a beta of 0.93. Milestone Scientific has a 52-week low of $0.58 and a 52-week high of $1.39.
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in MLSS. XTX Topco Ltd grew its stake in Milestone Scientific by 99.2% during the 1st quarter. XTX Topco Ltd now owns 34,135 shares of the company's stock worth $32,000 after buying an additional 17,002 shares during the last quarter. Brookwood Investment Group LLC purchased a new position in shares of Milestone Scientific in the 1st quarter valued at approximately $46,000. Renaissance Technologies LLC grew its stake in shares of Milestone Scientific by 72.8% in the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company's stock valued at $121,000 after purchasing an additional 53,198 shares during the last quarter. Finally, Carnegie Investment Counsel grew its stake in shares of Milestone Scientific by 18.9% in the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company's stock valued at $166,000 after purchasing an additional 27,412 shares during the last quarter. Hedge funds and other institutional investors own 5.79% of the company's stock.
About Milestone Scientific
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
